Jane Street Group, LLC Haemonetics Corp Call Options Transaction History

Jane Street Group, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$72.45 - $91.58 $5.78 Million - $7.31 Million	79,800 New	79,800 $6.41 Million
Q1 2022 May 17, 2022	SELL	$43.77 - $63.22 $542,748 - $783,928	-12,400 Reduced 65.61%	6,500 $411,000
Q4 2021 Feb 15, 2022	SELL	$49.55 - $74.59 $753,160 - $1.13 Million	-15,200 Reduced 44.57%	18,900 $1 Million
Q3 2021 Nov 16, 2021	BUY	$57.6 - $70.59 $126,720 - $155,298	2,200 Added 6.9%	34,100 $2.41 Million
Q2 2021 Aug 16, 2021	SELL	$51.81 - $118.56 $2.39 Million - $5.47 Million	-46,100 Reduced 59.1%	31,900 $2.13 Million
Q1 2021 May 18, 2021	BUY	$111.01 - $139.48 $3.56 Million - $4.48 Million	32,100 Added 69.93%	78,000 $8.66 Million
Q3 2020 Nov 17, 2020	BUY	$75.65 - $93.58 $3.47 Million - $4.3 Million	45,900 New	45,900 $4.01 Million

332

53.8M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.87B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.